Navigation Links
NxStage Extends Agreement to Supply Streamline Bloodlines, MasterGuard and Buttonhole Needle Technology to B. Braun
Date:1/9/2012

our continued commitment to provide B. Braun customers with market leading products," said Mark Florence, Vice President and General Manager, Medisystems. "We look forward to working with B. Braun to meet the growing demand for Streamline."

About B. Braun Renal Therapies Division

B. Braun has been a leader in providing the dialysis community with innovative products for over 35 years.  The Dialoghemodialysis system incorporates the most advanced state-of-the art technology in dialysis.  As a manufacturer and distributor of hemodialysis equipment and related disposables, including the Diacap @ Polysulfone® dialyzers, the Renal Therapies Division of B. Braun is committed to the continued development of high quality products for hemodialysis and continuous renal replacement therapy supported by a team of clinical nurses, field service personnel, customer service and 24/7 technical assistance.   For more information, call 800-848-2066, e-mail B. Braun at rtd.us@bbraun.com or visit B. Braun at www.bbraunusa.com.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. NxStage is leading the development of the home hemodialysis market in the US with the only portable hemodialysis machine, the System One, cleared for home use by the FDA. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com/.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NxStage Medical to Present at JMP Securities Healthcare Focus Conference
2. NxStage Announces Streamline(TM) Blood Tubing Set Supply Agreement with Renal Advantage Inc.
3. NxStage to Present at the JPMorgan Healthcare Conference
4. NxStage to Present at the Cowen and Company 29th Annual Healthcare Conference
5. NxStage to Report First Quarter 2009 Financial Results
6. NxStage Reports First Quarter 2009 Financial Results
7. NxStage Reports Second Quarter 2009 Financial Results
8. NxStage® Reports Record Revenue for the First Quarter of Fiscal 2011
9. Microbes, Inc. Extends Warrant Tender Offer
10. FDA Extends Review Timeline for Ustekinumab Biologic License Application Three Months
11. Sun Pharmaceutical Extends Tender Offer for Taro
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
(Date:12/22/2014)... PA & Brussels (PRWEB) December 22, 2014 ... (CfPIE), the global leader of technical training across ... Society for Clinical Data Management (SCDM) to provide ... and certification programs —providing access to the more ... partnership extends SCDM members with 10% off when registering ...
(Date:12/22/2014)... MISSION VIEJO, Calif. , Dec. 22, 2014 /PRNewswire/ ... announce that CoPatient, an online medical bill review and ... newest offering in the FREE WellCard Savings discount health ... a medical bill that was more than they expected ... help members reduce health care costs, WellCard Savings is ...
(Date:12/19/2014)... Charm Sciences is pleased to announce ... of Aflatoxin M1 in raw commingled milk is the ... validation. The peer reviewed report of the validation by ... Agricultural and Fisheries Research (ILVO-T&V) has been published by ... the most toxic aflatoxin and a known carcinogen, can ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... Md., Oct. 23 United,Therapeutics Corporation (Nasdaq: ... 2008 third quarter financial results before market open ... host a half-hour teleconference on Thursday,October 30, 2008, ... by dialing 1-800-603-1777, with international callers dialing,1-706-679-8129. A ...
... Soliris(R) in U.S. and Europe, Reported Net Sales ... Quarter Shipments, Company Revises Revenue Guidance Upward and ... 2008, Pipeline Progress in Hematology, Oncology, Transplant, Neurology, ... (eculizumab) net product sales of $76.5 million in Q3,2008 ...
... TheBrain,s dynamic interface enhances Web community and presence by visualizing ... , ... Marina del Rey, CA (PRWEB) ... software, announces that MedTechIQ has published several "Bioinfomediary Brains", on ...
Cached Biology Technology:Alexion Reports Third Quarter 2008 Results 2Alexion Reports Third Quarter 2008 Results 3Alexion Reports Third Quarter 2008 Results 4Alexion Reports Third Quarter 2008 Results 5Alexion Reports Third Quarter 2008 Results 6Alexion Reports Third Quarter 2008 Results 7Alexion Reports Third Quarter 2008 Results 8Alexion Reports Third Quarter 2008 Results 9Alexion Reports Third Quarter 2008 Results 10Alexion Reports Third Quarter 2008 Results 11Alexion Reports Third Quarter 2008 Results 12Alexion Reports Third Quarter 2008 Results 13Alexion Reports Third Quarter 2008 Results 14MedTechIQ Selects TheBrain to Visualize Expansive Biointellingence Database and Connect the Dots Between Life Sciences, Medicine and Venture Capital 2MedTechIQ Selects TheBrain to Visualize Expansive Biointellingence Database and Connect the Dots Between Life Sciences, Medicine and Venture Capital 3MedTechIQ Selects TheBrain to Visualize Expansive Biointellingence Database and Connect the Dots Between Life Sciences, Medicine and Venture Capital 4
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the ... a study that pinpoints fine-scale differences in genetic ancestry ... . Since immigrants first arrived more ... States has served as a meeting place ... American history and the ongoing mixing of peoples with ...
(Date:12/17/2014)... 2014 The Defense Logistics Agency is ... detect and prevent counterfeit microcircuits from entering into ... started performing an in-house microcircuit anti-counterfeit initiative dubbed ... of purchased microcircuits while increasing their reliability throughout ... will be conducted at DLA,s Electronics Product Test ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... ice formation occurred in the Arctic earlier than previously ... week in Nature . "The results are also ... in the Arctic before it did in Antarctica, which ... Richard Pearce of the University of Southampton,s School of ...
... 14, 2009 -- The stress of rising natural gas prices ... homes. For some this means moving towards modern alternative ... traditional method for a solution to these rising costs. ... been reevaluated as a potentially viable option for home heating. ...
... Va.The Journal of Vascular and Interventional Radiology ,s quality ... years, and the increase in its impact factor to 2.217 ... radiology, nuclear medicine and medical imaging journals, according to results ... continues to see a rise in its impact, the Society ...
Cached Biology News:Early initiation of Arctic sea-ice formation 2Early initiation of Arctic sea-ice formation 3Wood stoves -- a viable home heat source? 2Journal of Vascular and Interventional Radiology increases impact, international reach 2Journal of Vascular and Interventional Radiology increases impact, international reach 3
No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
15(S)-HETE-d8 is used as an internal standard for the quantification of 15(S)-HETE by stable isotope dilution mass spectrometry....
...
...
Biology Products: